X

XBiotech

D
XBIT
USD
-0.8
(-9.697%)
Market Closed
6,103.00
Volume
EPS
-
Div Yield
-6.422414
P/E
226,950,512.20
Market Cap
Today
-1.4550%
1 Week
1.776%
1 Month
4.635%
6 Months
-19.459%
12 Months
85.323%
Year To Date
85.093%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments

Title:
XBiotech

Sector:
Healthcare
Industry:
Biotechnology
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
Do you need help or have a question?
Contact Us